Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Op. Grant: Knowledge Mobilization in Diabetes Prevention and Treatment - General

University of Alberta

$62,177.00

Freedom and Flexibility - Communicating the Experiences of Beta Cell Replacement to Patients and Providers

FY 2024-25

Summary
Incorporating insulin therapy into daily life for people living with Type 1 Diabetes (T1D) is complicated and demanding. Transplantation of islet cells (which make insulin) from a deceased organ donor has been pioneered in Canada over the last 25 years and has enabled more than 300 individuals to achieve normal blood glucose levels without the need to take insulin for 3 years on average. By 20 years transplants still function in half but only 10% of recipients are off insulin. Recipients enjoy freedom from hypoglycemia, smoother blood glucose levels and can reach glycemic targets. Recipients report that their transplant provides "freedom and flexibility" even if they are not completely insulin independent. Awareness of islet transplant as a treatment option among persons with T1D and health care providers is low, and there are several common misconceptions. These include 1) the transplants stop working very quickly, 2) the transplant is very risky, 3) the waiting lists are very long. Unlike other organ transplants, we discard around half of the donated pancreases because there is no matching recipient on our waiting list. Islet transplantation in Alberta is not generally available for residents of other provinces. We propose to record interviews with islet transplant recipients and their family members to better understand their experience of undergoing and then living with an islet transplant and the impact it has had on their lives. We will then develop short video testimonials to capture elements of the lived experience which will resonate with those with T1D and practitioners to better explain the challenges of living with diabetes that prompted people to have a transplant. These will be used by transplant programs, shared with diabetes communities, health care providers and policymakers. We hope this will build bridges between people with T1D and their care teams which helps understanding of why novel treatments beyond insulin are so eagerly desired.
Program
Op. Grant: Knowledge Mobilization in Diabetes Prevention and Treatment - General
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
506630
Name
Senior Peter A
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Breakthrough T1D Canada (Ontario)
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Clinical
Prcname2
Operating Grant: Knowledge Mobilization in Diabetes Prevention and Treatment
Projecttitle
Freedom and Flexibility - Communicating the Experiences of Beta Cell Replacement to Patients and Providers
Programtype2
Operating Grants
Orgnameinp2
University of Alberta
Cihramount2
$62,177
Cihrequipment2
$0
Programname2
Op. Grant: Knowledge Mobilization in Diabetes Prevention and Treatment - General
Keyworddelim
Cell Therapy; Islet Transplant; Patient Perspective; Qualitative Interviews; Type 1 Diabetes
Abstract
Incorporating insulin therapy into daily life for people living with Type 1 Diabetes (T1D) is complicated and demanding. Transplantation of islet cells (which make insulin) from a deceased organ donor has been pioneered in Canada over the last 25 years and has enabled more than 300 individuals to achieve normal blood glucose levels without the need to take insulin for 3 years on average. By 20 years transplants still function in half but only 10% of recipients are off insulin. Recipients enjoy freedom from hypoglycemia, smoother blood glucose levels and can reach glycemic targets. Recipients report that their transplant provides "freedom and flexibility" even if they are not completely insulin independent. Awareness of islet transplant as a treatment option among persons with T1D and health care providers is low, and there are several common misconceptions. These include 1) the transplants stop working very quickly, 2) the transplant is very risky, 3) the waiting lists are very long. Unlike other organ transplants, we discard around half of the donated pancreases because there is no matching recipient on our waiting list. Islet transplantation in Alberta is not generally available for residents of other provinces. We propose to record interviews with islet transplant recipients and their family members to better understand their experience of undergoing and then living with an islet transplant and the impact it has had on their lives. We will then develop short video testimonials to capture elements of the lived experience which will resonate with those with T1D and practitioners to better explain the challenges of living with diabetes that prompted people to have a transplant. These will be used by transplant programs, shared with diabetes communities, health care providers and policymakers. We hope this will build bridges between people with T1D and their care teams which helps understanding of why novel treatments beyond insulin are so eagerly desired.
Competitiondate
202405
Approvedterm2
1 yr 0 mth
Pinamesdelim
Senior, Peter A; Reeve, Rachel L; Crossman, Renee; Lam, Anna
Approvedterm
1 an 0 mois
Cihrcontribution2
MI #4~ $62,177~ $0~
University of Alberta - $62,177 Grant (2024-25) | Canada Spends